opioid withdrawal

opioid withdrawal

Substance abuse An acute state caused by withdrawal of opioid narcotics from a person addicted to narcotics Clinical Sweating, shaking, headache, craving, vomiting, abdominal cramping, diarrhea, insomnia, confusion, agitation, other behavioral changes. See Neonatal withdrawal syndrome.
References in periodicals archive ?
Structured, group-based, psychoeducational self-management interventions help people to better manage their daily lives with a long-term condition, including persistent pain, but few of these have specifically targeted patients considering opioid withdrawal.
Scientists studying the health of these infants have found a possible link between their opioid withdrawal, also known as neonatal abstinence syndrome, and the twisting condition called torticollis.
The Food and Drug Administration has cleared a medical device that uses electrical stimulation to cranial nerves, and head and neck nerves to reduce acute opioid withdrawal symptoms.
The Food and Drug Administration has cleared a medical device that applies electrical stimulation to cranial nerves in order to reduce opioid withdrawal symptoms.
M2 EQUITYBITES-November 22, 2017-US WorldMeds wins US FDA regulatory submission & priority review for non-opioid, non-addictive lofexidine for the management of opioid withdrawal
M2 PHARMA-November 22, 2017-US WorldMeds wins US FDA regulatory submission & priority review for non-opioid, non-addictive lofexidine for the management of opioid withdrawal
Symptoms of opioid withdrawal include agitation, sweating, shivering, tremor, diarrhea, nausea, and vomiting.
Given that opioid withdrawal - which typically isn't a medical emergency though it's very uncomfortable - is a miserable process.
All 20 patients survived, although no referrals for recovery support services, including treatment of substance use disorder, opioid addiction, opioid withdrawal, or harm reduction services (e.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has entered into an exclusive agreement with US WorldMeds, LLC for the commercial manufacture of lofexidine, an investigational drug under development to mitigate symptoms associated with opioid withdrawal and facilitate completion of opioid discontinuation treatment.
12) In addition, emergency department protocols for managing opioid withdrawal may provide an important entry point for engaging patients who use POs non-medically in care.